Ennogen Healthcare International Limited in Dartford, DA1 5BS

Description

Data updated on: 01-11-2023

2020 is the date that marks the beginning of Ennogen Healthcare International Limited, a firm registered at Unit G4 Riverside Industrial Estate, Riverside Way, Dartford. This means it's been four years Ennogen Healthcare International has existed in this business, as it was created on 2020-12-23. The firm registration number is 13097275 and the zip code is DA1 5BS. This enterprise's declared SIC number is 46460 and their NACE code stands for Wholesale of pharmaceutical goods. Its latest financial reports were submitted for the period up to 31st December 2021 and the most recent annual confirmation statement was filed on 22nd December 2022.

The information we have about this firm's personnel reveals that there are two directors: Jason T. and Gurdev R. who became a part of the team on 2022-06-14 and 2020-12-23.

The companies that control this firm include: Ennogen Investments Ltd owns over 3/4 of company shares. This business can be reached in Dartford at Riverside Way, DA1 5BS.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2021-12-31	2022-12-31
Currency

Balance Sheet
Cash Bank On Hand		5 040 859
Current Assets	1 000	13 686 330
Debtors	1 000	2 738 050
Net Assets Liabilities	1 000	60 916 028
Other Debtors	1 000	936 694
Property Plant Equipment		17 249
Total Inventories		5 907 421

Other Financial Data
Audit Fees Expenses		7 500
Accrued Liabilities Deferred Income		56 774
Accumulated Amortisation Impairment Intangible Assets		2 533 364
Accumulated Depreciation Impairment Property Plant Equipment		1 363
Additions Other Than Through Business Combinations Intangible Assets		51 239 059
Additions Other Than Through Business Combinations Property Plant Equipment		18 612
Administrative Expenses		4 945 186
Amortisation Expense Intangible Assets		2 533 364
Amounts Owed By Group Undertakings		1 713 303
Amounts Owed To Group Undertakings		1 499 914
Applicable Tax Rate		19
Average Number Employees During Period		39
Cash Cash Equivalents Cash Flow Value		5 040 859
Cash Flows Used In Acquiring Or Obtaining Control Subsidiaries Or Other Businesses Classified As Investing Activities		1
Comprehensive Income Expense		-1 484 972
Corporation Tax Payable		76 957
Cost Sales		2 511 287
Creditors		1 764 712
Current Tax For Period		76 957
Depreciation Expense Property Plant Equipment		1 363
Distribution Costs		561 385
Finished Goods		5 907 421
Fixed Assets		48 994 410
Gain Loss In Cash Flows From Change In Accrued Items		56 774
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables		131 067
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables	-1 000	-2 737 050
Gain Loss In Cash Flows From Change In Inventories		-5 907 421
Gain Loss On Non-financing Activities Due To Foreign Exchange Differences Recognised In Profit Or Loss		415
Gross Profit Loss		4 092 027
Income Expense Recognised Directly In Equity	1 000	62 400 000
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation		5 040 859
Increase Decrease In Net Debt From Cash Flows		3 540 945
Increase From Amortisation Charge For Year Intangible Assets		2 533 364
Increase From Depreciation Charge For Year Property Plant Equipment		1 363
Intangible Assets		48 705 695
Intangible Assets Gross Cost		51 239 059
Interest Income On Bank Deposits		7 619
Interest Paid Classified As Operating Activities		1 090
Interest Payable Similar Charges Finance Costs		1 090
Interest Received Classified As Operating Activities		7 619
Investments		271 466
Investments Fixed Assets		271 466
Investments In Group Undertakings		1
Issue Equity Instruments	1 000	62 400 000
Net Cash Flows From Used In Financing Activities	1 000	63 899 914
Net Cash Flows From Used In Investing Activities		-51 529 137
Net Cash Flows From Used In Operating Activities	-1 000	-7 329 918
Net Current Assets Liabilities	1 000	11 921 618
Net Debt Funds		-3 540 945
Operating Profit Loss		-1 414 544
Other Creditors		12 938
Other Finance Costs		1 090
Other Interest Receivable Similar Income Finance Income		7 619
Other Investments Other Than Loans		271 465
Other Taxation Social Security Payable		74 065
Par Value Share	1	1
Pension Costs Defined Contribution Plan		36 136
Pension Other Post-employment Benefit Costs Other Pension Costs		36 136
Prepayments Accrued Income		88 053
Proceeds From Issuing Shares	1 000	62 400 000
Proceeds From Repayment Loans Advances To Group Undertakings Classified As Financing Activities		1 499 914
Profit Loss		-1 484 972
Profit Loss On Ordinary Activities Before Tax		-1 408 015
Property Plant Equipment Gross Cost		18 612
Purchase Intangible Assets		51 239 059
Purchase Property Plant Equipment		18 612
Research Development Expense Recognised In Profit Or Loss		466 121
Revenue From Sale Goods		6 603 314
Social Security Costs		66 103
Staff Costs Employee Benefits Expense		789 055
Tax Expense Credit Applicable Tax Rate		-267 523
Tax Increase Decrease From Effect Capital Allowances Depreciation		343 359
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss		1 121
Tax Tax Credit On Profit Or Loss On Ordinary Activities		76 957
Total Assets Less Current Liabilities	1 000	60 916 028
Trade Creditors Trade Payables		44 064
Turnover Revenue		6 603 314
Wages Salaries		686 816
Company Contributions To Money Purchase Plans Directors		2 420
Director Remuneration		24 367
Director Remuneration Benefits Excluding Payments To Third Parties		26 787
Called Up Share Capital Not Paid Not Expressed As Current Asset	1 000
Number Shares Allotted	1 000

Company staff

Jason T.

Role: Director

Appointed: 14 June 2022

Latest update: 25 April 2024

Gurdev R.

Role: Director

Appointed: 23 December 2020

Latest update: 25 April 2024

People with significant control

Ennogen Investments Ltd

Address: Unit G4 Riverside Way, Dartford, DA1 5BS, England

Legal authority Companies Act 2006

Legal form Private Limited Company

Notified on 1 January 2022

Nature of control:

over 3/4 of shares

Gurdev R.

Notified on 23 December 2020

Ceased on 1 January 2022

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	31 December 2023
Account last made up date	31 December 2021
Confirmation statement next due date	05 January 2024
Confirmation statement last made up date	22 December 2022

Annual Accounts
Start Date For Period Covered By Report	2020-12-23
End Date For Period Covered By Report	2021-12-31
Annual Accounts
Start Date For Period Covered By Report	2022-01-01
End Date For Period Covered By Report	31/12/2022

Ennogen Healthcare International Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Jason T.

Gurdev R.

People with significant control

Ennogen Investments Ltd

Gurdev R.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode